ArticleAsian journal of neurosurgery2025
Microvascular Decompression for Trigeminal Neuralgia Secondary to Vertebrobasilar Dolichoectasia: A Case Report and Review of the Literature.
Article in Asian journal of neurosurgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vertebrobasilar dolichoectasia (VBD) is a vasculopathy characterized by elongation and dilation of the affected artery. We present a case of trigeminal neuralgia (TN) secondary to VBD, successfully treated with microvascular decompression (MVD) using an autologous muscle graft (AMG). Additionally, we conducted a review of the literature and meta-analysis of 14 studies involving 303 patients to evaluate the efficacy of this surgical approach. A 63-year-old man experienced recurrent, lancinating pain in the V1, V2, and V3 branches of the right trigeminal nerve. Due to the intractable symptoms, he underwent MVD with an AMG after thorough neurological evaluation. At the 1-year follow-up, he was pain-free without the need for further medication. TN secondary to VBD is a rare and challenging condition, often refractory to medical treatment. MVD with an AMG offers significant symptom relief. Further research, including prospective studies or randomized controlled trials comparing AMG with other graft materials, is necessary to confirm its efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.